Patent details

EP3883579 Title: COMBINATION THERAPY INCLUDING A KRAS-G12C INHIBITOR AND ONE OR MORE ADDITIONAL PHARMACEUTICALLY ACTIVE AGENTS FOR THE TREATMENT OF CANCERS

Basic Information

Publication number:
EP3883579
PCT Application Number:
US2019062064
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP198866832
PCT Publication Number:
WO2020106647
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION THERAPY INCLUDING A KRAS-G12C INHIBITOR AND ONE OR MORE ADDITIONAL PHARMACEUTICALLY ACTIVE AGENTS FOR THE TREATMENT OF CANCERS
French Title of Invention:
POLYTHÉRAPIE INCLUANT UN INHIBITEUR DE KRAS G12C ET UN OU PLUSIEURS PRINCIPES PHARMACEUTIQUEMENT ACTIFS SUPPLÉMENTAIRES POUR LE TRAITEMENT DE CANCERS
German Title of Invention:
KOMBINATIONSTHERAPIE, EINSCHLIESSLICH EINES KRAS-G12C-INHIBITORS UND EINES ODER MEHRERER ZUSÄTZLICHER PHARMAZEUTISCHER WIRKSTOFFE FÜR DIE BEHANDLUNG VON KREBS
SPC Number:

Dates

Filing date:
18/11/2019
Grant date:
24/12/2025
EP Publication Date:
29/09/2021
PCT Publication Date:
28/05/2020
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/12/2025
EP B1 Publication Date:
24/12/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
18/11/2039
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/12/2025
 
 

Name:
Amgen Inc.
Address:
One Amgen Center Drive, Thousand Oaks CA 91320, United States (US)

Agent

Name:
ARONOVA S.A.
From:
20/01/2026
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
REX, Karen Louise
Address:
United States (US)

2

Name:
LIPFORD, James Russell
Address:
United States (US)

3

Name:
SAIKI, Anne Y.
Address:
United States (US)

4

Name:
CANON, Jude Robert
Address:
United States (US)

Priority

1

Priority Number:
201862769355 P
Priority Date:
19/11/2018
Priority Country:
United States (US)

2

Priority Number:
201962821376 P
Priority Date:
20/03/2019
Priority Country:
United States (US)

3

Priority Number:
201962865819 P
Priority Date:
24/06/2019
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/555; A61K 31/506; A61K 31/519; A61K 45/06; A61P 35/00; A61K 39/395; C07K 16/28;

Publication

European Patent Bulletin

Issue number:
202552
Publication date:
24/12/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/11/2026
Annual Fee Number:
8
Annual Fee Amount:
99 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
20/01/2026 Power Of Attorney 1
21/01/2026 Outgoing Correspondence 1